首页 > 市场调查报告书 > 製药

生物製剂

合成生物学市场规模、份额和成长分析（按工具、应用、技术和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1899865

合成生物学市场规模、份额和成长分析（按工具、应用、技术和地区划分）－2026-2033年产业预测

Synthetic Biology Market Size, Share, and Growth Analysis, By Tool (Oligonucleotides and Synthetic DNA, Enzymes), By Application (Medical Application, Pharmaceuticals), By Technology, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，合成生物学市场价值将达到 178 亿美元，到 2025 年将成长至 223.4 亿美元，到 2033 年将成长至 1374.7 亿美元，在预测期（2026-2033 年）内复合年增长率为 25.5%。

在技术创新和对永续解决方案日益增长的需求的推动下，合成生物学市场预计将显着扩张。 Cas9和CRISPR基因编辑技术以及合成基因合成等技术的快速发展，正在提高合成生物学应用的成本效益和实用性。环境问题和对永续性的迫切需求，促使人们更加关注开发环保解决方案，包括绿色化学品、可生物降解材料和生质燃料。然而，关于基因改造和生物安全的伦理问题和严格的法规结构，对商业化和研究倡议构成了挑战。儘管存在这些障碍，先进治疗方法和个人化医疗的出现，为变革医疗保健和解决以往无法治癒的疾病提供了巨大潜力，展现了其对产业的变革性影响。

全球合成生物学市场按工具、应用、技术和地区进行细分。依工具划分，可分为寡核苷酸和合成DNA、酵素、克隆技术试剂盒、合成细胞、底盘生物体和异源核酸。按应用划分，可分为医疗应用、製药、药物发现和治疗、其他医疗应用、人工组织和组织再生、工业应用、其他行业、食品和农业以及环境应用。依技术划分，可分为基因合成、基因组工程、定序、生物资讯学、特异性诱变、克隆、测量和建模、微流体和奈米技术。按地区划分，可分为北美、欧洲、亚太、中东和非洲以及拉丁美洲。

合成生物学市场驱动因素

合成生物学市场正经历显着成长，这主要得益于创新治疗方法、诊断方法和疫苗研发的进步，这些技术在医疗保健和製药行业的应用日益广泛。此外，该技术在培育抗病虫害能力更强的基因改造作物方面也发挥关键作用，有助于提高农业生产力并增强粮食安全。这些变革性的能力共同推动了对合成生物学解决方案日益增长的需求，最终促进了整个市场的扩张。随着各行各业逐渐认识到其潜在优势，合成生物学的影响范围也不断扩大，涵盖了许多应用领域。

合成生物学市场限制因素

合成生物学市场面临许多挑战，其中技术研发的高昂初始成本限制了其扩充性和普及性。此外，合成生物学系统的设计、建构和整合过程的复杂性也构成了重大障碍，可能损害这些创新技术的整体可靠性和效率。企业在克服这些障碍的过程中，可能会遇到阻碍其发展和产业内广泛应用的限制。因此，合成生物学相关的财务负担和技术难题有可能抑制这一充满前景却又复杂的领域的成长和投资，从而限制其对各个行业的潜在影响。

合成生物学市场趋势

随着新兴企业逐渐意识到基因表现、表观遗传学和DNA序列之间复杂交互作用所带来的挑战，合成生物学市场正呈现表观遗传技术创新的显着趋势。合成构建体过度活化导致的不一致性凸显了基因工程领域对更精确、更可控方法的需求。新参与企业正在开发先进的解决方案，以更有效地操控表观遗传因子，从而提高合成生物学应用的可靠性和可预测性。这种对克服表观遗传学挑战的关注有望推动包括农业、医疗保健和工业生物技术在内的多个领域的进步。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 义大利
- 法国
- 英国
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲（MEA）
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争格局

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市集活动
主要企业市占率（2025 年）

主要企业简介

[if!supportLists][endif]Thermo Fisher Scientific, Inc.（US）
Merck KGaA（Germany）
Agilent Technologies（US）
Novozymes（Denmark）
Ginkgo Bioworks（US）
Amyris（US）
Precigen, Inc.（US）
GenScript（China）
Twist Bioscience（US）
Synthetic Genomics（US）
Codexis, Inc.（US）
Synthego（US）
Creative Enzymes（US）
Eurofins Scientific（Luxembourg）
Bota Biosciences Inc.（China）
Creative Biogene（US）
Enbiotix, Inc.（US）
Illumina, Inc.（US）
New England Biolabs（US）
Pareto Bio, Inc.（US）

简介目录

Product Code: SQMIG35H2209

Synthetic Biology Market size was valued at USD 17.8 Billion in 2024 and is poised to grow from USD 22.34 Billion in 2025 to USD 137.47 Billion by 2033, growing at a CAGR of 25.5% during the forecast period (2026-2033).

The synthetic biology market is poised for substantial expansion driven by innovations and an increasing demand for sustainable solutions. Rapid advancements in technologies such as Cas9 and CRISPR gene editing, alongside synthetic gene synthesis, enhance the cost-effectiveness and practicality of synthetic biology applications. Heightened interest in creating eco-friendly solutions, including green chemicals, biodegradable materials, and biofuels, is fueled by environmental concerns and the urgent need for sustainability. However, ethical issues and stringent regulatory frameworks concerning genetic modifications and biosafety present challenges to commercialization and research initiatives. Despite these obstacles, the emergence of advanced therapies and personalized medicine holds significant promise for revolutionizing healthcare and addressing previously untreatable conditions, marking a transformative potential for the industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Synthetic Biology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Synthetic Biology Market Segments Analysis

The global synthetic biology market is segmented by Tool, Application, Technology, and Region. Based on Tool, the market is segmented into Oligonucleotides and Synthetic DNA, Enzymes, Cloning Technologies Kits, Synthetic Cells, Chassis Organisms, and Xeno-Nucleic Acids. Based on Application, the synthetic biology market is segmented into Medical Application, Pharmaceuticals,Drug Discoveryand Therapeutics, Other Medical Application, Artificial Tissue and Tissue Regeneration, Industrial Applications, Other Industries, Food & Agriculture, Environmental Applications. Based on Technology, the market is segmented into Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Site-directed Mutagenesis, Cloning, Measurement and Modelling, Microfluidics, and Nanotechnology. By Region, the synthetic biology market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.

Driver of the Synthetic Biology Market

The synthetic biology market is experiencing significant growth driven by advancements in creating innovative therapies, diagnostics, and vaccines, which are enhancing applications in the healthcare and pharmaceutical industries. Additionally, this technology plays a crucial role in developing genetically engineered crops that possess heightened resistance to diseases and pests, thereby contributing to agricultural productivity and bolstering food security. The combination of these transformative capabilities is fostering an increased demand for synthetic biology solutions, ultimately propelling the overall expansion of this market. As various sectors recognize the potential benefits, the influence of synthetic biology continues to expand across diverse applications.

Restraints in the Synthetic Biology Market

The synthetic biology market faces significant challenges due to the high initial costs associated with developing these technologies, which can limit both scalability and accessibility. Additionally, the complexities involved in engineering, designing, and integrating synthetic biology systems can pose considerable obstacles, undermining the overall reliability and efficiency of these innovations. As companies navigate these hurdles, they may encounter constraints that hinder progress and adoption within the industry. Consequently, the financial burden and technical difficulties associated with synthetic biology could stifle growth and investment in this promising yet intricate field, restricting its potential impact on various sectors.

Market Trends of the Synthetic Biology Market

The Synthetic Biology market is witnessing a significant trend towards innovation in epigenetics technologies, as emerging companies recognize the challenges posed by the complex interplay between gene expression, epigenetics, and DNA sequences. The inconsistencies arising from over-activation of synthetic constructs have highlighted the need for more precise and controlled approaches in genetic engineering. New entrants are developing advanced solutions that enable better manipulation of epigenetic factors, thereby enhancing the reliability and predictability of synthetic biology applications. This focus on overcoming epigenetic challenges is poised to drive advancements in various sectors, including agriculture, healthcare, and industrial biotechnology.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Patent Analysis
Pricing Analysis
Regulatory Analysis
Value Chain Analysis
Ecosystem of the Market
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Synthetic Biology Market by Tool

Market Overview
Oligonucleotides and Synthetic DNA
Enzymes
Cloning Technologies Kits
Synthetic Cells
Chassis Organisms
Xeno-nucleic Acids

Synthetic Biology Market by Technology

Market Overview
Gene Synthesis
Genome Engineering
Sequencing, Bioinformatics
Site-directed Mutagenesis
Cloning
Measurement and Modelling
Microfluidics
Nanotechnology

Synthetic Biology Market by Application

Market Overview

Synthetic Biology Market Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- Italy
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

[if !supportLists] [endif] Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novozymes (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ginkgo Bioworks (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amyris (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Precigen, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Twist Bioscience (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synthetic Genomics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Codexis, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synthego (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Enzymes (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bota Biosciences Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Biogene (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enbiotix, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
New England Biolabs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pareto Bio, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments